Accelerating Medtech Innovation Through AI-Enabled Product Development
June 24, 2026
12:00 PM – 1:00 PM
Join Kearney as they explore how medtech organizations are using AI to transform product development and accelerate innovation.
Presented by Kearney
Accelerating Medtech Innovation Through AI-Enabled Product Development
June 24, 2026
12:00 PM – 1:00 PM
Accelerating Medtech Innovation Through AI-Enabled Product Development
June 24, 2026
12:00 PM – 1:00 PM
Join Kearney to explore how leading medtech organizations are using AI to transform product development and accelerate innovation. We’ll outline how AI can unify data, enable real-time cross-functional collaboration, and surface key trade-offs earlier in the development lifecycle. Beyond tools, Kearney will discuss the operating model changes required to fully capture value from AI in product development.
Drawing on our recent work with global medtech leaders, we will illustrate how companies have shortened development cycles, improved product outcomes, and increased organizational alignment. Attendees will leave with a clear understanding of how to connect human expertise, institutional data, and AI, along with practical guidance on taking the first concrete steps toward applying these approaches in their own product development organizations.
What You’ll Cover
- Where AI is delivering value today across the product lifecycle
- High-impact use cases in practice (i.e., connecting data, teams, and workflows)
- Operating model implications (i.e., What needs to change to embed AI into product development)
- Lessons learned from implementation
- Getting started: a practical path forward
Date: Wednesday, June 24, 2026
Time: 12:00 PM – 1:00 PM ET
Location: Online
Meet the Speakers
Kushal Fernandes, Partner, Kearney
Kushal Fernandes is a Partner at Kearney and a co-founder of the Product Excellence and Renewal Lab (PERLab). He specializes in product development and design-to-value, helping organizations apply data- and AI-driven approaches to improve product performance and accelerate innovation. He has been closely involved in developing and applying AI-enabled approaches to product development, including Kearney’s Velocity platform.
Erik Blazic, Partner, Kearney
Erik Blazic is a Partner at Kearney and Global Lead for MedTech. He brings over a decade of industry experience from General Motors and deep consulting expertise across the healthcare value chain, including medical device manufacturers & distributors. Erik specializes in product development, operations, and supply chain transformation, helping organizations apply digital and AI-driven approaches to improve performance and accelerate innovation. He has led numerous engagements with global MedTech leaders, delivering practical, results-oriented solutions to complex challenges.
Stuart Klein, Partner, Kearney
Stuart Klein is a Partner at Kearney and leads the firm’s Life Sciences Digital and Analytics efforts, with a focus on MedTech AI transformation. He brings more than 15 years of experience helping organizations leverage Data, Digital, and AI to improve operational performance, accelerate decision-making, and drive enterprise transformation. Stuart specializes in AI-enabled transformation across the MedTech value chain, including supply chain, operations, R&D, and commercial functions. He supports leading MedTech organizations on enterprise AI strategy, AI-driven operating models, process redesign, and the deployment of AI solutions at scale to drive measurable business impact.
Craig Hebert, Partner, Kearney
Craig Hebert is a Partner at Kearney and core member of the Life Sciences Practice with focus in MedTech. He brings nearly 20 years of expertise in Life Sciences and is a former R&D and Quality Engineer that has contributed to the development and launch of 3 separate billion-dollar products. Craig specializes in Product Innovation, Strategic Operations, and Quality while integrating leading perspectives across AI, Digital, and Data.
Hear From Us
Sign up to receive emails highlighting our upcoming events, early registration savings, and engagement opportunities for the medical technology community.